Primary Record
Ginsenoside Rd
- In stock
- 5,926 g
- Purity
- 99.3 %
- CAS
- 52705-93-8
Compound Identifiers & Properties
- CAS
- 52705-93-8
- PubChem CID
- 11679800
- SMILES
- CC(=CCC[C@@](C)([C@H]1CC[C@@]2([C@@H]1[C@@H](C[C@H]3[C@]2(CC[C@@H]4[C@@]3(CC[C@@H](C4(C)C)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O)C)C)O)C)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O)C
- Canonical SMILES
- CC(C)=CCC[C@](C)(O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C(C)(C)[C@@H]3CC[C@]12C
Names & Synonyms
- Ginsenoside Rd
- Gypenoside VIII
- ginsenoside-Rd
- Chikusetsusaponin fk7
- 52705-93-8
- GS-Rd
- G-Rd
- RefChem:37442
- (20S)-ginsenoside Rd
- 20(S)-ginsenoside Rd
- WB232T95AV
- (GS)-Rd
- CHEMBL473659
- RLDVZILFNVRJTL-IWFVLDDISA-N
- DTXSID301031221
- UNII-WB232T95AV
- CHEBI:67988
- SCHEMBL669260
- MFCD00799993
- DTXCID701516233
- HMS3885A14
- HY-N0043
- MSK40199
- EINECS 258-118-5
- BDBM50317539
- C48H82O18
- NP6989
- s3931
- AKOS037514671
- ZINC253387933
- ACN-035847
- CCG-270588
- CID 432448
- CS-3839
- EBC-618393
- CID11679800
- GINSENOSIDE RD (REFERENCE GRADE)
- NCGC00522501-01
- CID:11679800
- J61.215D
- SID:134224739
- FT-0626703
- FT-0777116
- G0550
- C20725
- A829210
- C049863
- Q27136471
- (2S,3R,4S,5S,6R)-2-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-[[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-12-hydroxy-4,4,8,10,14-pentamethyl-17-[(2S)-6-methyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhept-5-en-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol
- (2S,3R,4S,5S,6R)-2-[(2R,3R,4S,5S,6R)-4,5-Dihydroxy-6-(hydroxymethyl)-2-[[(3S,8R,9R,10R,12R,13R,14R,17S)-12-hydroxy-4,4,8,10,14-pentamethyl-17-[(2S)-6-methyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhept-5-en-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol
- 2-O-beta-D-Glucopyranosyl-(3beta,12beta)-20-(beta-D-glucopyranosyloxy)-12-hydroxydammara-24-en-3-yl-beta-D-glucopyranoside
- (2S,3R,4S,5S,6R)-2-{[(2S)-2-[(1S,3aR,3bR,5aR,7S,9aR,9bR,11R,11aR)-7-{[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-11-hydroxy-3a,3b,6,6,9a-pentamethyl-hexadecahydro-1H-cyclopenta[a]phenanthren-1-yl]-6-methylhept-5-en-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
- (20S)-3beta-[(2-O-beta-D-Glucopyranosyl-beta-D-glucopyranosyl)oxy]-20-(beta-D-glucopyranosyloxy)-5alpha-dammara-24-ene-12beta-ol
- (20S)-3beta-[[2-O-(beta-D-Glucopyranosyl)-beta-D-glucopyranosyl]oxy]-20-(beta-D-glucopyranosyloxy)dammaran-24-ene-12beta-ol
- (20S)-3beta-[2-O-(beta-D-Glucopyranosyl)-beta-D-glucopyranosyloxy]-20-(beta-D-glucopyranosyloxy)dammar-24-ene-12beta-ol
- (2S,3R,4S,5S,6R)-2-((2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-(((3S,5R,8R,9R,10R,12R,13R,14R,17S)-12-hydroxy-4,4,8,10,14-pentamethyl-17-((2S)-6-methyl-2-((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl)oxyhept-5-en-2-yl)-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta(a)phenanthren-3-yl)oxy)oxan-3-yl)oxy-6-(hydroxymethyl)oxane-3,4,5-triol
- (2S,3R,4S,5S,6R)-2-[(2R,3R,4S,5S,6R)-2-[[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-17-[(1S)-1,5-dimethyl-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-hex-4-enyl]-12-hydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-4,5-dihydroxy-6-(hydroxymethyl)tetrahydropyran-3-yl]oxy-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol
- (3b,12b)-20-(b-D-Glucopyranosyl)oxy]-12-hydroxydammar-24-en-3-yl2-O-(b-D-glucopyranosyl)-b-D-glucopyranoside
- (3beta,12beta)-20-(beta-D-glucopyranosyloxy)-12-hydroxydammar-24-en-3-yl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside
- (3beta,12beta,20S)-20-[(beta-D-glucopyranosyl)oxy]-3-[(beta-D-glucopyranosyl-(1->2)-beta-D-glucopyranosyl)oxy]dammar-24-en-12-ol
- .BETA.-D-GLUCOPYRANOSIDE, (3.BETA.,12.BETA.)-20-(.BETA.-D-GLUCOPYRANOSYLOXY)-12-HYDROXYDAMMAR-24-EN-3-YL 2-O-.BETA.-D-GLUCOPYRANOSYL-
- [20-(beta-D-Glucopyranosyloxy)-12beta-hydroxydammar-24-en-3beta-yl]2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside
- 20(S)-protopanaxadiol-3-[O-beta-D-glucopyranosyl(1->2)-beta-D-glucopyranoside]-20-(O-beta-D-glucopyranoside)
- 20-(beta-D-Glucopyranosyloxy)-12beta-hydroxy-5alpha-dammar-24-ene-3beta-yl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside
- 258-118-5
- 3-O-(beta-D-glucopyranosyl-(1->2)-beta-D-glucopyranosyl)-20-O-beta-D-glucopyranosyl-20(S)-protopanaxadiol
- 3beta-[2-O-(beta-D-Glucopyranosyl)-beta-D-glucopyranosyloxy]-20-(beta-D-glucopyranosyloxy)dammar-24-ene-12beta-ol
- b-D-Glucopyranoside,(3b,12b)-20-(b-D-glucopyranosyloxy)-12-hydroxydammar-24-en-3-yl2-O-b-D-glucopyranosyl-
- beta-D-Glucopyranoside, (3-beta,12-beta)-20-(beta-D-glucopyranosyloxy)-12-hydroxydammar-24-en-3-yl 2-O-beta-D-glucopyranosyl-
- GINSENOSIDE RD (CONSTITUENT OF AMERICAN GINSENG, ASIAN GINSENG, AND TIENCHI GINSENG) [DSC]
- ss-D-Glucopyranoside, (3ss,12ss)-20-(ss-D-glucopyranosyloxy)-12-hydroxydammar-24-en-3-yl 2-O-ss-D-glucopyranosyl-; Dammarane, ss-D-glucopyranoside deriv.; (3ss,12ss)-20-(ss-D-Glucopyranosyloxy)-12-hydroxydammar-24-en-3-yl 2-O-ss-D-glucopyranosyl-ss-D-glucopyranoside; 3-O-ss-D-Glucopyranosyl-(1?2)-ss-D-glucopyranosyl-20-O-ss-D-glucopyranosyldammar-24-ene-3ss,12ss,20S-triol; Chikusetsusaponin FK7; Ginsenoside Rd; Ginsenoside Rd1; Gypenoside VIII